Treatment of chronic rhinosinusitis with low-dose, long-term macrolide antibiotics: An evolving paradigm

Current Allergy and Asthma Reports

Volumn 5, Issue 6, 2005, Pages 491-494

  Hatipoglu, Umur ^a   Rubinstein, Israel ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHEMOKINE; CLARITHROMYCIN; CORTICOSTEROID; CYTOKINE; ERYTHROMYCIN; MACROLIDE; ROXITHROMYCIN;

ANTIBIOTIC THERAPY; CHLAMYDOPHILA PNEUMONIAE; CHRONIC INFLAMMATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; LONG TERM CARE; LOW DRUG DOSE; MYCOPLASMA PNEUMONIAE; NONHUMAN; NOSE MUCOSA; PARANASAL SINUS; PATHOPHYSIOLOGY; REVIEW; RHINOSINUSITIS; STOMACH PAIN; SYMPTOMATOLOGY;

EID: 28044453107     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-005-0031-y     Document Type: Review

References (32)

1. Benninger MS, Ferguson BJ, Hadley JA, et al.: Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003, 129(3Suppl):S1-S32.
2. Van Cauwenberge P, Watelet JB: Epidemiology of chronic rhinosinusitis. Thorax 2000, 55(Suppl 2):S20-S21.
3. Ray NF, Baraniuk JN, Thamer M, et al.: Health care expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and upper airway disorders. J Allergy Clin Immunol 1999, 103(3 Pt 1):408-414.
4. Demoly P, Crampette L, Mondain M, et al.: Assessment of inflammation in noninfectious chronic maxillary sinusitis. Allergy Clin Immunol 1994, 94:95-108.
5. Nishimoto K, Kotaro U, Teruhiko H, et al.: Lymphocyte subsets in maxillary mucosa in chronic inflammation. Acta Otolaryngol (Stockh 1) 1982, 106:291-298.
6. Suzuki H, Takahashi Y, Wataya H, et al.: Mechanism of neutrophil recruitment and induced by IL-8 in chronic sinusitis. J hAllergy Clin Immunol 1996, 98:659-670.
7. Bachert C, Hauser U, Prem B, et al.: Proinflammatory cytokines in allergic rhinitis. Eur Arch Otorhinolaryngol Suppl 1995, 1:S44-S99.
8. Border W, Ruoslahti E: Transforming growth factor beta in disease: the dark side of tissue repair. J Clin Invest 1992, 90:1-7.
9. Coste A, Lefaucher J, Wang Q, et al.: Expression of the transforming growth factor beta isoforms in inflammatory cells of nasal polyps. Arch Otolaryngol Head Neck Surg 1998, 124:1361-1366.
10. Sugiyama Y: Diffuse panbronchiolitis. Clin Chest Med 1993, 14:765-772.
11. Kudoh S, Uetake T, Hagiwara K, et al.: Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Jpn J Thorac Dis 1987, 25:632-642.
12. Hoiby N: Diffuse panbronchiolitis and cystic fibrosis: East meets West. Thorax 1994, 49:531-532.
13. Wolter J, Seeney S, Bell S: Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax 2002, 57:212-216.
14. Hotta M: Neutrophil chemotactic activity in cryptogenic organizing pneumonia and the response to erythromycin. Kurume Med J 1996, 43:207-217.
15. Cazzola M, Salzillo A, Diamare F: Potential role of macrolides in the treatment of asthma. Monaldi Arch Chest Dis 2000, 55:231-236.
16. Sugiyama Y, Yanagisawa K, Tominaga SI, et al.: Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages. Eur Resp J 1999, 14:1113-1116.
17. Suzuki H, Asada Y, Ikeda Y, et al.: Inhibitory effect of erythromycin on interleukin 8 secretion from exudative cells in the nasal discharge of patients with chronic sinusitis. Laryngoscope 1999, 109:407-410.
18. Suzuki H, Takahashi Y, Wataya H, et al.: Mechanism of neutrophil recruitment induced by IL-8 in chronic sinusitis. Allergy Clin Immunol 1996, 98:659-670.
19. Wallwork B, Coman W, Mackay-Sim A, et al.: Effect of clarithromycin on nuclear factor kappaB and transforming growth factor beta in chronic rhinosinusitis. Laryngoscope 2004, 114:286-290.
20. Wallwork B, Coman W, Feron F, et al.: Clarithromycin and prednisolone inhibits cytokine production in chronic rhinosinusitis. Laryngoscope 2002, 112:1827-1830.
21. Rubin BK, Druce H, Ramirez OE, et al.: Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis. Am J Resp Crit Care Med 1997, 155:2018-2023.
22. Tamaoki J, Takeyama K, Tagaya E, et al.: Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections. Antimicrob Agents Chemother 1995, 39:1688-1690.
23. Shimizu T, Shimizu S, Hattori R, et al.: In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells. Am J Respir Crit Care Med 2003, 168:581-587.
24. Oshiba M, Baba S: Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol 1996, 525(Suppl):73-78.
25. Ichimura K, Shimazaki Y, Ishibashi T, et al.: Effect of the macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx 1996, 23:48-56.
26. Suzuki H, Ikeda K, Honma R, et al.: Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. ORL J Otorhinolaryngol Relat Spec 2000, 62:121-127.
27. Yamada T, Fujieda S, Mori S, et al.: Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 2000, 14:143-148.
28. Iino Y, Sugita K, Toriyama M, et al.: Erythromycin therapy for otitis media with effusion in sinobronchial syndrome. Arch Otolaryngol Head Neck Surg 1993, 119:648-651.
29. Cervin A, Kalm O, Sandkull P, et al.: Low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg 2002, 126:481-489.
30. MacLeod CM, Hamid QA, Cameron L, et al.: Anti-inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa. Adv Ther 2001, 18:75-82.
31. Black PN, Blasi F, Jenkins CR, et al.: Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 2001, 164:536-541.
32. Hatipoglu U, Rubinstein I: Analysis of exhaled breath condensate: potential implications for diagnosis and therapy of lung diseases. In New Perspectives in Monitoring of Lung Inflammation: Analysis of Exhaled Breath Condensate. Edited by Montuschi P. Boca Raton, FL: CRC Press, 2004:123-138.